Algorae Pharmaceuticals (ASX:1AI)
ASX announcement history & article coverage
Transparent by design.
Announcments by Algorae Pharmaceuticals (ASX:1AI) are listed here, whether we covered it or not. Where we've written an article, you'll see it linked directly. Where we haven't, the filing is still shown so nothing is hidden from view. If you think a particular announcement deserved editorial coverage and was overlooked, you can flag it for review and our team will take a look.
Date of AGM and Closing Date for Director Nominations
Notification of cessation of securities - 1AI
Appendix 4G and Corporate Governance Statement
Appendix 4E and 2026 Annual Report
Algorae Pharmaceuticals reports increased net loss and expands commercial operations in FY2026
Quarterly Activities Report/Appendix 4C Cashflow Statement
Algorae Pharmaceuticals expands commercial agreements, advances TGA registrations, scales AI pipeline, and secures NSW Health contract
Initial Director's Interest Notice - TV
Final Director's Interest Notice - BD
Notification of cessation of securities - 1AI
Nasdaq Pharma Chairman Troy Valentine Joins Algorae Board
Cleansing Notice
Application for quotation of securities - 1AI
Peter Mac Testing Validates AlgoraeOS v2
Algorae Pharmaceuticals validates improved AlgoraeOS v2 drug synergy prediction platform with positive preclinical results
Updated - NSW Health Public Hospital Supply Contract
Algorae Pharmaceuticals appointed supplier under NSW Health public hospital contract with rollout underway
Algorae Awarded NSW Health Public Hospital Supply Contract
Algorae awarded NSW Health public hospital supply contract with rollout starting Q4 2026
Company Secretary Appointment/Resignation
Algorae Named Launch Partner for Sovereign AI Initiative
Change of Auditor
Cleansing Notice
Application for quotation of securities - 1AI
Application for quotation of securities - 1AI
Proposed issue of securities - 1AI